Rachelle Suzanne Jacques - Chief Executive Officer, Director at Akari Therapeutics Plc

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Executive Officer, Director
Stock Symbol
AKTX on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Rachelle Suzanne Jacques since 9/18/2023

Holdings reported by Rachelle Suzanne Jacques for Akari Therapeutics Plc

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Ordinary Shares, par value $0.0001 per share 1.02B Apr 26, 2024 Direct

Transactions reported by Rachelle Suzanne Jacques for Akari Therapeutics Plc

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.